Sun Pharma Appoints Kirti Ganorkar as Managing Director, Succeeding Dilip Shanghvi

Sun Pharmaceutical Industries has named Kirti Ganorkar as its new Managing Director effective September 1, 2025, succeeding Dilip Shanghvi, who will transition to Executive Chairman. The move marks a key succession step in Sun Pharma’s leadership strategy.

Sun Pharma Appoints Kirti Ganorkar as Managing Director, Succeeding Dilip Shanghvi
Kirti Ganorkar

Sun Pharmaceutical Industries Ltd. has announced a significant leadership transition, naming Kirti Ganorkar as the next Managing Director, effective September 1, 2025. This move is part of a well-structured succession planning process and remains subject to shareholder approval at the upcoming Annual General Meeting.

Ganorkar will succeed Dilip Shanghvi, who will continue as Executive Chairman, focusing on strategic initiatives and the company’s growing specialty portfolio. As MD, Ganorkar will oversee all business operations and functions globally.

Also Read: Even 0.01 BTC Could Make You Rich by 2027, Says Rich Dad Poor Dad Author Robert Kiyosaki

Having joined Sun Pharma in 1996, Kirti Ganorkar brings nearly three decades of diverse experience within the organisation. He is currently heading Sun Pharma’s India Business, a role he has held since mid-2019. During his tenure, the company has achieved consistent growth in the domestic market, further strengthening its position and market share.

Throughout his long association with the company, Ganorkar has contributed significantly across multiple strategic areas, including business development, product launches, M&A, marketing, IP, and litigation. He has also played a pivotal role in Sun Pharma’s expansion into international markets, driving its initial entry into Japan and laying the foundation for its European presence. He was instrumental in advancing the U.S. generics business and helped shape Sun Pharma’s focus on specialty pharmaceuticals, notably securing key products such as Ilumya.

Also Read: ‘Bail Yourself Out’: Rich Dad Poor Dad Author Predicts Major Financial Crisis, urges People to ditch ‘Fake Fiat Money’

Commenting on his elevation, Ganorkar said, “It has been a profoundly rewarding journey to participate in the company’s transformation into a leading global pharmaceutical enterprise. Sun Pharma is at an exciting juncture with all its businesses well-positioned for growth.”

Dilip Shanghvi stated, “Kirti has consistently demonstrated effective leadership managing diverse roles at Sun. I have a firm belief in his ability to lead the company into its next phase of growth.”

Share
Scroll to Top